Literature DB >> 7902413

Predicting medication compliance in a psychotic population.

S G Adams1, J T Howe.   

Abstract

The compliance level of 42 acutely psychotic inpatients was assessed using a locally constructed standard interview and written questionnaire. Subjects rated their level of compliance and indicated variables that were associated with compliance and noncompliance. Reliable items from the written questionnaire were grouped into five categories: side effects, difficulties obtaining medication, reinforcement for not taking medication, symptom relief, and indirect benefits. A stepwise multiple regression indicated that indirect benefits accounted for 18% of the variance in the self-report measure of compliance. It was concluded that psychotic patients who recognize benefits that are secondary to symptom relief are more likely to comply with their medication regimen. The results suggest a need for research on variables associated with noncompliance and potential treatment interventions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902413     DOI: 10.1097/00005053-199309000-00005

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  16 in total

1.  Social interaction and drug attitude effectiveness in patients with schizophrenia.

Authors:  Jui-Kang Tsai; Wen-Kuo Lin; For-Wey Lung
Journal:  Psychiatr Q       Date:  2011-12

2.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Authors:  Martijn J Kikkert; Aart H Schene; Maarten W J Koeter; Debbie Robson; Anja Born; Hedda Helm; Michela Nose; Claudia Goss; Graham Thornicroft; Richard J Gray
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

Review 3.  Compliance therapy for schizophrenia.

Authors:  A M McIntosh; L Conlon; S M Lawrie; A C Stanfield
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 4.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

5.  Adherence to medication regimens and participation in dual-focus self-help groups.

Authors:  Stephen Magura; Alexandre B Laudet; Daneyal Mahmood; Andrew Rosenblum; Edward Knight
Journal:  Psychiatr Serv       Date:  2002-03       Impact factor: 3.084

6.  Compliance therapy: a randomised controlled trial in schizophrenia.

Authors:  Colin O'Donnell; Gary Donohoe; Louise Sharkey; Nicholas Owens; Maria Migone; Raewynn Harries; Anthony Kinsella; Conall Larkin; Eadbhard O'Callaghan
Journal:  BMJ       Date:  2003-10-11

Review 7.  Long-acting injectable antipsychotics in the elderly: guidelines for effective use.

Authors:  Prakash S Masand; Sanjay Gupta
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  High risk factors for rehospitalization within six months.

Authors:  R Walker; D Minor-Schork; R Bloch; J Esinhart
Journal:  Psychiatr Q       Date:  1996

9.  What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders.

Authors:  Subho Chakrabarti
Journal:  World J Psychiatry       Date:  2014-06-22

10.  Progress and compliance in alcohol abuse treatment.

Authors:  Hsien-Ming Lien; Mingshan Lu; Ching-To Albert Ma; Thomas G McGuire
Journal:  J Health Econ       Date:  2009-11-26       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.